Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer Grant US-RE49353-E1 United States of America 03 Jan 2023
Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer Grant US-11491149-B2 United States of America 08 Nov 2022
Substituted thiohydantoin derivatives as androgen receptor antagonists Grant US-10981926-B2 United States of America 20 Apr 2021
ANTI-ANDROGENS FOR THE TREATMENT OF NON-METASTATIC CASTRATE-RESISTANT PROSTATE CANCER Grant EP-3305285-B1 European Patent Office 02 Sep 2020